Advertisement
Opinion

Mounjaro for all! Will Wes Streeting’s plan for weight loss jabs on the NHS really work?

Giving people Mounjaro to reverse conditions such as type 2 diabetes could be seen as an investment in future health costs. But it’s not that simple

It slipped through, broadly unacknowledged. But it’s a piece of thinking that could bring major ramifications for how Britain lives.

You’ve probably already forgotten much of what was declared at the Labour Party annual conference in Liverpool. That’s understandable. You have a life to live, pets to de-worm, small jobs about the place to put off. 

Conferences are curious happenings. Members of the main parties gather, frequently in seaside towns and cities, to listen to speeches about why they are how they are, and why they need to be better at it/prouder of it. 

There might be a few interesting fringe events and debates and photo-ops. Political journalists hear things in bars. Then leaders make stirring keynotes and people stand up and down applauding an awful lot. Quite the jolly.

Get the latest news and insight into how the Big Issue magazine is made by signing up for the Inside Big Issue newsletter

While much of what Wes Streeting, the health secretary, said was taking aim at Reform, his announcement about a shiny new online health service to cure many ills was the takeaway headline. But he said something much more seismic. He suggests weight-loss jabs could be available to millions on the NHS. He’s made similar noises before

Advertising helps fund Big Issue’s mission to end poverty
Advertisement

At present, these weight-loss drugs are widely available through pharmacists, but expensive to patients. They vary somewhat in price but all well over £100 for the basic dose. 

Asda Online Doctor, for instance, lists Mounjaro starting at £168.97 for four doses. This covers a month. That’s at a basic level so can rise according to need.

Streeting believes the cost is a barrier that makes it, essentially, a two-tier health system – one for the haves and one for the have nots.

Read more:

“The wealthy talk about how they’ve transformed their health, their confidence, their quality of life. But
what about the millions who can’t afford them? 

“That is a return to the days when health was determined by wealth. When some had access to the best care money can buy, while others waited and suffered. And I say: never again,” he said, insistently.

Advertising helps fund Big Issue’s mission to end poverty

The exact cost is unknown. It had previously been announced that some jabs will be available to more people on the NHS in England over the next three years. 

But due to Donald Trump’s tariff jiggery-pokery, costs of Mounjaro have risen steeply in recent times. It’s unclear where they’ll settle. 

To expand from tens of thousands to hundreds of thousands would put much more pressure on a creaking NHS.

An argument can be made that this is an investment in the future. If it was prescribed, costs to treat diseases related to obesity and excess weight – like type 2 diabetes and heart conditions – would drop. 

It could dramatically, and quickly, improve the lifestyle and outcomes of many people. Some in government will start to talk about the potential for improving productivity in work and moving some people from long-term sick.

This is laudable. But it doesn’t seem sustainable. It doesn’t deal with underlying issues, around diet, income and other socio-economic factors that can contribute to obesity. 

Advertising helps fund Big Issue’s mission to end poverty

The ongoing questions about lasting effects of weight-loss jabs also remain unanswered. 

Maybe Wes Streeting will see his plan change Britain for good. It would certainly be popular. The government could do with any positive goals they can score.

It’s symptom not the cause, though. And that eventually is going to come unstuck.

Paul McNamee is editor of the Big Issue.Read more of his columns here. Follow him on X.

Do you have a story to tell or opinions to share about this? Get in touch and tell us more

Reader-funded since 1991 – Big Issue brings you trustworthy journalism that drives real change.

Advertising helps fund Big Issue’s mission to end poverty

Every day, our journalists dig deeper, speaking up for those society overlooks.

Could you help us keep doing this vital work? Support our journalism from £5 a month.

Advertising helps fund Big Issue’s mission to end poverty

READER-SUPPORTED SINCE 1991

Reader-supported journalism that doesn’t just report problems, it helps solve them.

Recommended for you

Read All
Is going to university really worth it?
Dr Craig Henry Jones

Is going to university really worth it?

Universal credit is back in the dock – this time at the United Nations
Delegates from around the world at the United Nations.
Rick Burgess and Alex Firth

Universal credit is back in the dock – this time at the United Nations

Supermarket dominance is disastrous for food prices, public health and the planet
supermarket aisle
Carina Millstone

Supermarket dominance is disastrous for food prices, public health and the planet

Housing refugees properly benefits everyone in society – here's how
a tent on the street
Lauren Aronin

Housing refugees properly benefits everyone in society – here's how

Most Popular

Read All
Renters pay their landlords' buy-to-let mortgages, so they should get a share of the profits
Renters: A mortgage lender's window advertising buy-to-let products
1.

Renters pay their landlords' buy-to-let mortgages, so they should get a share of the profits

Exclusive: Disabled people are 'set up to fail' by the DWP in target-driven disability benefits system, whistleblowers reveal
Pound coins on a piece of paper with disability living allowancve
2.

Exclusive: Disabled people are 'set up to fail' by the DWP in target-driven disability benefits system, whistleblowers reveal

Cost of living payments: Where to get help in 2025 now the scheme is over
next dwp cost of living payment 2023
3.

Cost of living payments: Where to get help in 2025 now the scheme is over

Citroën Ami: the tiny electric vehicle driving change with The Big Issue
4.

Citroën Ami: the tiny electric vehicle driving change with The Big Issue